Israeli researchers developed a new RNA-based blood test for early Parkinson's detection. The test measures specific RNA fragments, accurately identifying pre-symptomatic patients with 86% accuracy. This surpasses current methods, enabling earlier interventions and improved patient outcomes. Early detection is crucial as Parkinson's is often diagnosed after significant brain damage.
